<DOC>
	<DOCNO>NCT03069612</DOCNO>
	<brief_summary>Cannabis use adolescence represent significant risk factor development psychosis include schizophrenia . Moreover , cannabis commonly use drug among patient exist psychotic disorder . An estimated 25 % patient psychosis reportedly meet criterion cannabis use disorder particularly among young patient experience first episode . Cannabis use significantly exacerbate symptomatology result increased duration first hospitalization visit , number hospital readmission , overall reduce functional outcome . Discovering novel strategy treat underlie pathophysiology cannabis dependence early disorder may translate improved functional outcome . Working memory deficit show predict relapse first-year psychosis modulate cannabis use . Repetitive transcranial magnetic stimulation ( rTMS ) target dorsolateral prefrontal cortex ( DLPFC ) show tremendous promise treatment tobacco dependence work memory impairment patient psychosis possibly modulation gamma ( 30-50 Hz ) oscillation . The propose study therefore evaluate effect rTMS abstinence , work memory performance , gamma oscillation randomize , double-blind , placebo-controlled 28-day longitudinal abstinence study design patient early psychosis . It explore baseline performance gamma oscillation predict abstinence response rTMS . It hypothesize active compare sham rTMS improve abstinence rate improve work memory performance modulation gamma oscillation .</brief_summary>
	<brief_title>rTMS Treatment Cannabis Use Disorders Psychosis</brief_title>
	<detailed_description>This randomize , double-blind placebo-controlled , longitudinal 28-Day abstinence study design . Patients psychosis randomize ( 1:1 ) receive either active sham stimulation administer three time per week 4 week ( 28 day ) total 12 treatment . Urine collect three time per week prior rTMS treatment . Cognition include N-Back task MATRICS cognitive battery administer Day 0 , Day 28 , Day 42 determine effect rTMS cognition compare sham stimulation .</detailed_description>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>Age 1635 Meet Diagnostic Statistical Manual Mental Disorders ( DSM ) 5 diagnostic criterion cannabis use disorder physiological evidence dependence ; plus one schizophrenia , schizoaffective disorder , schizophreniform disorder , delusional disorder , bipolar I disorder , major depressive disorder psychotic feature , cannabisinduced psychosis , psychosis otherwise specify Full scale IQ ≥ 80 determined Wechler Test Adult Reading ( WTAR ) Daily cigarette smoker ≥ 5 cigarette per day DSM5 diagnose alcohol , substance polyuse substance use disorder past 6 month ( cannabis/caffeine nicotine ) Currently active suicidal ideation selfharm ( suicidal nonsuicidal ) Head injury result loss consciousness hospitalization Major neurological medical illness include seizure disorder syncope Metallic implant History rTMS treatment Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>repetitive transcranial magnetic stimulation</keyword>
	<keyword>work memory</keyword>
	<keyword>gamma oscillation</keyword>
	<keyword>dorsolateral prefrontal cortex</keyword>
</DOC>